Harnessing m1A modification: a new frontier in cancer immunotherapy
Xinru Wang1, Xiaoqing Ma1, Siyu Chen1
1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Frontiers in Immunology
|December 17, 2024
Summary
N1-methyladenosine (m1A) RNA modification impacts tumor immunity by influencing immune cells and the tumor microenvironment. m1A also aids in predicting cancer prognosis and guiding personalized immunotherapies.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Immunology
Background:
- N1-methyladenosine (m1A) is a crucial RNA epigenetic modification.
- Enzymes like methyltransferases, demethylases, and m1A-binding proteins regulate m1A.
- m1A influences RNA structure, stability, translation, metabolism, and gene expression, impacting biological processes.
Purpose of the Study:
- To review the multifaceted role of m1A modification in tumor immunity.
- To explore how m1A impacts immune cells and the tumor microenvironment.
- To discuss m1A's role in metabolic reprogramming and its connection to immune checkpoint inhibitors for novel immunotherapeutic strategies.
Main Methods:
- Literature review and synthesis of existing research on m1A modification in cancer and immunity.
- Analysis of m1A's regulatory mechanisms and functional consequences.
- Exploration of m1A-based biomarkers and therapeutic potential.
Main Results:
- m1A modification directly and indirectly influences anti-tumor immune responses.
- m1A-mediated metabolic reprogramming is linked to immune checkpoint inhibitor efficacy.
- The m1AScore, derived from m1A expression patterns, shows potential for predicting tumor prognosis and guiding personalized treatment.
Conclusions:
- m1A modification represents a significant factor in cancer biology and immuno-oncology.
- Targeting m1A offers promising avenues for developing innovative cancer immunotherapies.
- m1A-based approaches, including the m1AScore, could personalize cancer treatment strategies.
Keywords:
cancer immunotherapyimmune checkpoint inhibitorm1A modificationm1AScoretumor microenvironmentMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:30Cancer Vaccines
338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338